Cargando…
Blocking insulin-like growth factor 1 receptor signaling pathway inhibits neuromuscular junction regeneration after botulinum toxin-A treatment
Botulinum toxin-A (BTX) administration into muscle is an established treatment for conditions with excessive muscle contraction. However, botulinum therapy has short-term effectiveness, and high-dose injection of BTX could induce neutralizing antibodies against BTX. Therefore, prolonging its effects...
Autores principales: | Ishihara, Hiroki, Otani, Yoshinori, Tanaka, Kazuki, Miyajima, Hisao, Ngo, Huy Xuan, Fujitani, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505167/ https://www.ncbi.nlm.nih.gov/pubmed/37717026 http://dx.doi.org/10.1038/s41419-023-06128-w |
Ejemplares similares
-
Pathophysiological Roles of Abnormal Axon Initial Segments in Neurodevelopmental Disorders
por: Fujitani, Masashi, et al.
Publicado: (2021) -
Do Neurotrophins Connect Neurological Disorders and Heart Diseases?
por: Fujitani, Masashi, et al.
Publicado: (2021) -
Maternal and Adult Interleukin-17A Exposure and Autism Spectrum Disorder
por: Fujitani, Masashi, et al.
Publicado: (2022) -
Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction
por: Duregotti, Elisa, et al.
Publicado: (2015) -
Efficacy of Botulinum Toxin for Treating Sialorrhea in Neuromuscular Conditions
por: Singh, Harsh, et al.
Publicado: (2020)